BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 11, 2009
View Archived Issues
AIPL1 gene therapy shows promise for retinal dystrophies / News in Context
Read More
Alnylam and Tekmira enter research collaboration for systemic delivery of RNAi therapeutics
Read More
FDA places Repros' INDs for Proellex on clinical hold for safety reasons
Read More
Eden and Omnio sign agreement for production of protein candidate for wound healing
Read More
GSK to acquire Nabi's PentaStaph pentavalent S. aureus vaccine
Read More
Nanotherapeutics updates clinical progress of NanoBUP and NanoDOX
Read More
Antisoma to discontinue development of AS-1402 for breast cancer
Read More
European Commission grants orphan drug designation to Alexion's Soliris in aHUS
Read More
High interpatient variability of sildenafil exposure in neonates with PHT
Read More
Escitalopram treatment reduces benzodiazepine withdrawal symptoms
Read More
BLX-155 shows thrombolytic efficacy in porcine model of arteriovenous graft failure
Read More
Solulin restores cerebral blood flow and reduces infarct size in thrombotic stroke model
Read More
Diannexin exhibits potent in vitro and in vivo antithrombotic effects
Read More
PharmaMar reports discovery of natural compounds for cancer treatment
Read More
AstraZeneca claims novel AR ligands for the treatment of prostate cancer
Read More
Banyu presents glucokinase activators for the treatment of diabetes and obesity
Read More
Avila Therapeutics discloses new protease inhibitors for hepatitis C virus infection
Read More
Lilly discovers new MR antagonists for chronic kidney disease therapy
Read More
Curis and Debiopharm enter license agreement for CUDC-305 and Hsp90 technology
Read More
Spectrum acquires full rights and intellectual property to Altair's RenaZorb in all fields
Read More
ViroPharma initiates dosing in phase I trial of nontoxigenic C. difficile
Read More
Hisamitsu reports results from phase II study of HOB-294 in overactive bladder
Read More
Sepracor submits NDS to Health Canada for Stedesa as adjunctive therapy for epilepsy
Read More
FDA advisory committee to meet in September 2009 to review Allos' NDA for pralatrexate
Read More
FDA approves new formulation of Actelion's Ventavis for PAH
Read More